REGN R&D to Revenue
Regeneron Pharmaceuticals · R&D to Revenue
REGN R&D to Revenue
Latest reported40.79%period ending
REGN FY R&D/Revenue (0.00% → 40.79%)
Latest values, visible window
High-resolution chart · PNG
REGN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 40.7881% | |
| 36.8469% | |
| 30.3929% | |
| 25.1058% | |
| 16.3138% | |
| 29.4112% | |
| 34.1543% | |
| 30.3675% | |
| 32.861% | |
| 40.0695% | |
| 37.665% | |
| 43.2219% | |
| 38.8999% | |
| 42.7003% | |
| 111.7984% | |
| 102.2853% | |
| 101.3835% | |
| 111.8562% | |
| 152.0716% | |
| 192.4788% | |
| 208.3634% | |
| 78.2079% | |
| 236.5758% | |
| 568.1554% | |
| 416.6022% | |
| 94.9052% | |
| 130.1449% | |
| 96.8586% | |
| 83.9879% | |
| 117.4274% | |
| 85.0365% | |
| 171.1207% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |